scholarly journals Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data

Genes ◽  
2019 ◽  
Vol 10 (10) ◽  
pp. 753 ◽  
Author(s):  
Wang ◽  
Li ◽  
Liu ◽  
Kinnebrew ◽  
Zhang ◽  
...  

Alternatively-activated pathways have been observed in biological experiments in cancer studies, but the concept had not been fully explored in computational cancer system biology. Therefore, an alternatively-activated pathway identification method was proposed and applied to primary breast cancer and breast cancer liver metastasis research using microarray data. Interestingly, the results show that cytokine-cytokine receptor interaction and calcium signaling were significantly enriched under both conditions. TGF beta signaling was found to be the hub in network topology analysis. In total, three types of alternatively-activated pathways were recognized. In the cytokine-cytokine receptor interaction pathway, four active alteration patterns in gene pairs were noticed. Thirteen cytokine-cytokine receptor pairs with inverse activity changes of both genes were verified by the literature. The second type was that some sub-pathways were active under only one condition. For the third type, nodes were significantly active in both conditions, but with different active genes. In the calcium signaling and TGF beta signaling pathways, node E2F5 and E2F4 were significantly active in primary breast cancer and metastasis, respectively. Overall, our study demonstrated the first time using microarray data to identify alternatively-activated pathways in breast cancer liver metastasis. The results showed that the proposed method was valid and effective, which could be helpful for future research for understanding the mechanism of breast cancer metastasis.

2020 ◽  
Vol 46 (2) ◽  
pp. e14
Author(s):  
Oskar Hemmingsson ◽  
Malin Sund ◽  
Helena Taflin ◽  
Marcus Sundén ◽  
Anne Andersson

HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S943
Author(s):  
E. Gringeri ◽  
R. Boetto ◽  
S.E. Pierobon ◽  
F.E. D'Amico ◽  
D. Bassi ◽  
...  

HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S639
Author(s):  
K. Kobryń ◽  
E. Kobryń ◽  
K. Kobryń ◽  
M. Nowosad ◽  
W. Patkowski ◽  
...  

2006 ◽  
Vol 88 (7) ◽  
pp. 639-642 ◽  
Author(s):  
D Lawes ◽  
A Chopada ◽  
A Gillams ◽  
W Lees ◽  
I Taylor

INTRODUCTION Patients with liver metastasis from breast cancer have a poor prognosis, although this may be improved by hepatectomy in a selected group with disease confined to the liver. We evaluate the effectiveness of radiofrequency ablation (RFA) as a cytoreductive strategy in the management of liver metastasis from primary breast cancer. PATIENTS AND METHODS Nineteen patients with hepatic metastasis from primary breast cancer underwent RFA of their liver lesions between April 1998 and August 2004. RESULTS The median age of the patients was 52 years (range, 32–69 years), 8 had disease confined to the liver, with 11 having stable extrahepatic disease in addition. Seven patients with disease confined to the liver at presentation are alive, as are 6 with extrahepatic disease, median follow-up after RFA was 15 months (range, 0–77 months). Survival at 30 months was 41.6%. In addition, 7 patients followed up for a median of 14 months (range, 2–29 months) remain alive and disease-free. RFA failed to control hepatic disease in 3 patients. RFA was not associated with any mortality or major morbidity. CONCLUSIONS Control of hepatic metastasis from breast cancer is possible using RFA and may lead to a survival benefit, particularly in those patients with disease confined to the liver.


2021 ◽  
Vol 53 ◽  
pp. S46
Author(s):  
V. Giannelli ◽  
R. Meniconi ◽  
N. Guglielmo ◽  
M. Colasanti ◽  
C. D'Ambrosio ◽  
...  

2016 ◽  
Vol 264 (1) ◽  
pp. 147-154 ◽  
Author(s):  
Eran Sadot ◽  
Ser Yee Lee ◽  
Constantinos T. Sofocleous ◽  
Stephen B. Solomon ◽  
Mithat Gönen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document